Purdue Pharma Can Protect Sackler Owners in Opioid Bankruptcy, Court Rules
NEW YORK—Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader ban...
Read More